Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Incannex Healthcare (IXHL) EBIT (2023 - 2025)

Historic EBIT for Incannex Healthcare (IXHL) over the last 3 years, with Q4 2025 value amounting to -$7.0 million.

  • Incannex Healthcare's EBIT fell 3978.82% to -$7.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$26.3 million, marking a year-over-year increase of 737.94%. This contributed to the annual value of -$23.8 million for FY2025, which is 2081.16% up from last year.
  • According to the latest figures from Q4 2025, Incannex Healthcare's EBIT is -$7.0 million, which was down 3978.82% from -$6.8 million recorded in Q3 2025.
  • Over the past 5 years, Incannex Healthcare's EBIT peaked at -$4.9 million during Q3 2023, and registered a low of -$9.7 million during Q2 2024.
  • For the 3-year period, Incannex Healthcare's EBIT averaged around -$6.8 million, with its median value being -$6.9 million (2025).
  • Per our database at Business Quant, Incannex Healthcare's EBIT surged by 3731.68% in 2024 and then crashed by 3978.82% in 2025.
  • Incannex Healthcare's EBIT (Quarter) stood at -$8.0 million in 2023, then soared by 37.32% to -$5.0 million in 2024, then plummeted by 39.79% to -$7.0 million in 2025.
  • Its EBIT stands at -$7.0 million for Q4 2025, versus -$6.8 million for Q3 2025 and -$7.5 million for Q2 2025.